Current and emerging adjuvant therapies in biliary atresia

Current and emerging adjuvant therapies in biliary atresia

Following Kasai hepatic portoenterostomy (HPE), most patients with biliary atresia will eventually require liver transplantation due to progressive cirrhosis and liver failure. Preventing liver transplantation, or even delaying eventual liver transplantation, is the key to improving long-term outcom...

Full description

Bibliographic Details
Main Authors: Scott C. Fligor, Thomas I. Hirsch, Savas T. Tsikis, Andrew Adeola, Mark Puder
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Pediatrics
Subjects:
biliary atresia
therapeutics
cholestasis
cholangitis
liver transplant
glucocorticoids
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.1007813/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2022.1007813/full

Similar Items